CD4 and AIDS: The World Health Organization (WHO) currently recommends that all HIV-infected TB patients receive co-trimoxazole and that patients with clinical evidence of AIDS or CD4+ T-lymphocyte counts (CD4) <350 cells/μL initiate ART during TB treatment [2].